Among 57,086 older adults, new gabapentin users demonstrated lower fall-related healthcare visits than duloxetine users, with ...

Individuals with cardiovascular disease could have an increased risk for advanced breast cancer at diagnosis, potentially ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Artificial intelligence technology has identified many more patients with osteoporosis than institutions can handle.

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on ...

The first human patient in the United States with a confirmed case of avian influenza has died, according to a press release ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Loneliness and social isolation have declined since the pandemic but still affect about one third of US adults aged 50-80 ...